Daniel Hurst

Background

Daniel graduated from the University of York in 2019 with a First Class Honours MChem degree, with a year in industry spent within AstraZeneca’s Early Discovery Oncology Chemistry team. During his final year, Daniel investigated the synthesis and use of Aryl Halides in Pharmaceutical Chemistry, focusing on the development of a late-stage fluorination reaction. Prior to joining Dehns in 2021, Daniel worked in the Cooper Group at the University of Liverpool, researching the use of mobile robotics for organic chemistry.

Higher Education

MChem (Hons), University of York, Chemistry (with a year in industry), 2019